-
Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials.
-
An estimated 4 million workers in the U.S. are struggling to work due to debilitating symptoms from long COVID. The government is urging employers to provide accommodations to keep them on the job.
-
The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead officials will push for an earlier release of the next generation boosters in the fall.
-
Dr. Kevin O'Connor, the White House physician, reports that President Joe Biden has "residual nasal congestion and minimal hoarseness" after four full days of Paxlovid treatment.
-
Manchin said he was experiencing mild symptoms, while Murkowski said she was experiencing flu-like symptoms.
-
It's a common dilemma in this summer of surging travel and surging COVID. If one member of a vacation party comes down with the virus, what steps can be taken to reduce the risk to others?
-
Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.
-
The 79-year-old president "will isolate at the White House and will continue to carry out all of his duties fully during that time," a White House statement said.
-
Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.
-
The Biden administration is considering expanding eligibility for a second COVID-19 booster to those under 50 to try to protect more people against the latest omicron surge.